Upperton Pharma Solutions
Matthew Chillman is a Principal Scientist at Upperton Pharma Solutions, where work since July 2016 has focused on development and manufacturing, particularly in formulation development and spray drying of pharmaceutical and biotechnology products. Prior roles at Upperton included Senior Manufacturing Scientist and Project Scientist, emphasizing research and development across various pharmaceutical products. Prior to this, Matthew gained experience in customer service as a waiter at Village Urban Resorts from November 2011 to June 2016, enhancing communication and teamwork skills. Matthew holds an MChem degree in Chemistry from Loughborough University, awarded in 2016.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.